Plasma Cytokine Levels and Cytokine Genetic Polymorphisms in Patients with Metastatic Breast Cancer Receiving High-Dose Chemotherapy

Plasma Cytokine Levels and Cytokine Genetic Polymorphisms in Patients with Metastatic Breast Cancer Receiving High-Dose Chemotherapy

Differences in the baseline levels of serum cytokines or in single-nucleotide polymorphisms (SNPs) in cytokine genes may be useful to predict outcomes for patients being treated for metastatic breast cancer. We have measured the plasma levels and characterized individual SNPs for IL-1RA, IL-1β, IL-2...

Full description

Bibliographic Details
Main Authors: Robert Lafrenie, Mary Bewick, Carly Buckner, Michael Conlon
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Immuno
Subjects:
breast cancer
interleukin-1 receptor antagonist
cytokines
chemotherapy
prognosis
Online Access:https://www.mdpi.com/2673-5601/3/1/2

Similar Items

Similar Items